跳至主要内容
临床试验/IRCT20181203041835N1
IRCT20181203041835N1招募中2 期

The effect of powdered green tea enriched with epigallocatchin gallate (EGCG) on some clinical, electrophysiological, biochemical, inflammatory and antioxidant parameters in patients with coronary artery disease, a randomized, triple blind clinical trial

Rafsanjan University of Medical Sciences0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • coronary artery stenosis above 50% at least in one of the major coronary arteries and clinical stability, based on the Gensini criteria
  • the willingness to participate in the study
  • Age 40 and older

排除标准

  • include allergy to green tea or components and green tea products
  • the use of any antioxidant supplement
  • daily intake of green tea before and during the study
  • follow a special diet
  • participate in another study
  • alcohol intake
  • candidate for surgery Coronary artery bypass graft (CABG)
  • perceptual disorders
  • unstable angina
  • Diseases such as kidney and urinary tract and osteoporosis

研究者

相似试验